logo-loader

BioLargo reveals 60% rise in 3Q revenue amidst roll-out of PPE disinfectant spray Clyraguard

Published: 16:41 09 Oct 2020 BST

BioLargo Inc (OTCQB:BLGO) CEO Dennis Calvert tell Proactive the group posted third-quarter results on Thursday that saw its revenue jump 60% year-over-year on the back of contributions from all four of its divisions including its subsidiary Clyra Medical Technologies. Clyra Medical Technologies President Steve Harrison adds that the group has successfully executed the first phase of the Clyraguard product launch, a personal disinfectant spray designed to decontaminate masks and other PPE, which is now available at www.clyramedical.com.

FTSE rises ahead of Easter weekend, JD Sport gains on upbeat outlook -...

The FTSE 100 gained on the final morning of this shortened Easter trading week. Festive cheer was limited though, as Thames Water confirmed shareholders would not provide it with a £500 million rescue package, prompting speculation over the London supplier’s future. On a more positive...

17 minutes ago